141 related articles for article (PubMed ID: 34994613)
1. Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (SI-NETs).
Perez K; Kulke MH; Chittenden A; Ukaegbu C; Astone K; Alexander H; Brais L; Zhang J; Garcia J; Esplin ED; Yang S; Da Silva A; Nowak JA; Yurgelun MB; Garber J; Syngal S; Chan J
JCO Precis Oncol; 2021 Nov; 5():808-816. PubMed ID: 34994613
[TBL] [Abstract][Full Text] [Related]
2. A
Dumanski JP; Rasi C; Björklund P; Davies H; Ali AS; Grönberg M; Welin S; Sorbye H; Grønbæk H; Cunningham JL; Forsberg LA; Lind L; Ingelsson E; Stålberg P; Hellman P; Tiensuu Janson E
Endocr Relat Cancer; 2017 Aug; 24(8):427-443. PubMed ID: 28634180
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a heritable contribution to neuroendocrine tumors of the small intestine.
Neklason DW; VanDerslice J; Curtin K; Cannon-Albright LA
Endocr Relat Cancer; 2016 Feb; 23(2):93-100. PubMed ID: 26604321
[TBL] [Abstract][Full Text] [Related]
4. Driver mutations occur frequently in metastases of well-differentiated small intestine neuroendocrine tumours.
Samsom KG; Levy S; van Veenendaal LM; Roepman P; Kodach LL; Steeghs N; Valk GD; Wouter Dercksen M; Kuhlmann KFD; Verbeek WHM; Meijer GA; Tesselaar MET; van den Berg JG
Histopathology; 2021 Mar; 78(4):556-566. PubMed ID: 32931025
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
6. Familial small-intestine carcinoids: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.
de Mestier L; Pasmant E; Fleury C; Brixi H; Sohier P; Féron T; Diebold MD; Clauser E; Cadiot G;
Dig Liver Dis; 2017 Jan; 49(1):98-102. PubMed ID: 27825921
[TBL] [Abstract][Full Text] [Related]
7. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.
Elias E; Ardalan A; Lindberg M; Reinsbach SE; Muth A; Nilsson O; Arvidsson Y; Larsson E
Nat Commun; 2021 Nov; 12(1):6367. PubMed ID: 34737276
[TBL] [Abstract][Full Text] [Related]
8. Genetic associations with neuroendocrine tumor risk: results from a genome-wide association study.
Du Y; Ter-Minassian M; Brais L; Brooks N; Waldron A; Chan JA; Lin X; Kraft P; Christiani DC; Kulke MH
Endocr Relat Cancer; 2016 Aug; 23(8):587-94. PubMed ID: 27492634
[TBL] [Abstract][Full Text] [Related]
9. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
11. Genetics and epigenetics in small intestinal neuroendocrine tumours.
Stålberg P; Westin G; Thirlwell C
J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
[TBL] [Abstract][Full Text] [Related]
12. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
13. Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.
Vanni I; Pastorino L; Andreotti V; Comandini D; Fornarini G; Grassi M; Puccini A; Tanda ET; Pastorino A; Martelli V; Mastracci L; Grillo F; Cabiddu F; Guadagno A; Coco S; Allavena E; Barbero F; Bruno W; Dalmasso B; Bellomo SE; Marchiò C; Spagnolo F; Sciallero S; Berrino E; Ghiorzo P
J Transl Med; 2024 May; 22(1):462. PubMed ID: 38750555
[TBL] [Abstract][Full Text] [Related]
14. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
15. Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.
Simbolo M; Vicentini C; Mafficini A; Fassan M; Pedron S; Corbo V; Mastracci L; Rusev B; Pedrazzani C; Landoni L; Grillo F; Cingarlini S; Rindi G; Luchini C; Scarpa A; Lawlor RT
Virchows Arch; 2018 Dec; 473(6):709-717. PubMed ID: 30219970
[TBL] [Abstract][Full Text] [Related]
16. Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing.
Backman S; Norlén O; Eriksson B; Skogseid B; Stålberg P; Crona J
Anticancer Res; 2017 Feb; 37(2):705-712. PubMed ID: 28179320
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Association Study Identifies 4 Novel Risk Loci for Small Intestinal Neuroendocrine Tumors Including a Missense Mutation in LGR5.
Giri AK; Aavikko M; Wartiovaara L; Lemmetyinen T; Karjalainen J; Mehtonen J; Palin K; Välimäki N; Tamlander M; Saikkonen R; Karhu A; Morgunova E; Sun B; Runz H; Palta P; Luo S; Joensuu H; Mäkelä TP; Kostiainen I; Schalin-Jäntti C; FinnGen ; Palotie A; Aaltonen LA; Ollila S; Daly MJ
Gastroenterology; 2023 Oct; 165(4):861-873. PubMed ID: 37453564
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes.
Mossanen M; Nassar AH; Stokes SM; Martinez-Chanza N; Kumar V; Nuzzo PV; Kwiatkowski DJ; Garber JE; Curran C; Freeman D; Preston M; Mouw KW; Kibel A; Choueiri TK; Sonpavde G; Rana HQ
Clin Genitourin Cancer; 2022 Dec; 20(6):568-574. PubMed ID: 36127252
[TBL] [Abstract][Full Text] [Related]
20. Absence of somatic SDHD mutations in sporadic neuroendocrine tumors and detection of two germline variants in paraganglioma patients.
Perren A; Barghorn A; Schmid S; Saremaslani P; Roth J; Heitz PU; Komminoth P
Oncogene; 2002 Oct; 21(49):7605-8. PubMed ID: 12386824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
